Immunomagnetic separation combined with RT-qPCR for determining the efficacy of disinfectants against human noroviruses

Pengbo Liu, Myung Kim, David Schlesinger, Christine Kranz, Sangdo Ha, Jeehyoung Ha, James Slauch, Seungbum Baek, Christine Moe

Research output: Contribution to journalArticle

Abstract

Little is known about the effectiveness of disinfectants against human noroviruses (NoV) partially because human NoV cannot be routinely cultured in laboratory. The objective of this study was to develop a NoV monoclonal antibody-conjugated immunomagnetic separation (IMS) procedure combined with real-time reverse transcription polymerase chain reaction (RT-qPCR) assays to study the in vitro efficacy of disinfectants against human NoV. Monoclonal antibodies against Norwalk virus (NV, GI.1) and NoV GII.4 were produced using unique NoV capsid proteins, and the antibodies were conjugated to magnetic Dynalbeads. The immunomagnetic beads were used to simultaneously capture intact NoV in samples and effectively remove PCR inhibitors. We examined the efficacy of ethanol, sodium hypochlorite, nine commercially available disinfectants, and one prototype disinfectant using the IMS/RT-qPCR. The sensitivity of this procedure was approximately 100 virus particles for both the NV and GII.4 viruses. The average log reductions in in vitro activities varied between disinfectants. The prototype disinfectant produced an average 3.19-log reduction in NV and a 1.38-log reduction in GII.4. The prototype disinfectant is promising of inactivating NoV. This method can be used to evaluate in vitro activity of disinfectants against human NoV. The IMS/RT-qPCR method is promising as an effective method to remove PCR inhibitors in disinfectants and enable the evaluation of the efficacy of disinfectants.

Original languageEnglish (US)
Pages (from-to)145-154
Number of pages10
JournalJournal of Infection and Public Health
Volume8
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Immunomagnetic Separation
Norovirus
Disinfectants
Polymerase Chain Reaction
Norwalk virus
Monoclonal Antibodies
Sodium Hypochlorite
Capsid Proteins
Virion
Reverse Transcription
Ethanol

Keywords

  • Disinfectant
  • Immunomagnetic separation
  • Norovirus
  • PCR inhibition
  • Real-time RT-PCR

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Immunomagnetic separation combined with RT-qPCR for determining the efficacy of disinfectants against human noroviruses. / Liu, Pengbo; Kim, Myung; Schlesinger, David; Kranz, Christine; Ha, Sangdo; Ha, Jeehyoung; Slauch, James; Baek, Seungbum; Moe, Christine.

In: Journal of Infection and Public Health, Vol. 8, No. 2, 01.01.2015, p. 145-154.

Research output: Contribution to journalArticle

Liu, Pengbo ; Kim, Myung ; Schlesinger, David ; Kranz, Christine ; Ha, Sangdo ; Ha, Jeehyoung ; Slauch, James ; Baek, Seungbum ; Moe, Christine. / Immunomagnetic separation combined with RT-qPCR for determining the efficacy of disinfectants against human noroviruses. In: Journal of Infection and Public Health. 2015 ; Vol. 8, No. 2. pp. 145-154.
@article{0ca9f778a03d42b880bb1fb194593ee0,
title = "Immunomagnetic separation combined with RT-qPCR for determining the efficacy of disinfectants against human noroviruses",
abstract = "Little is known about the effectiveness of disinfectants against human noroviruses (NoV) partially because human NoV cannot be routinely cultured in laboratory. The objective of this study was to develop a NoV monoclonal antibody-conjugated immunomagnetic separation (IMS) procedure combined with real-time reverse transcription polymerase chain reaction (RT-qPCR) assays to study the in vitro efficacy of disinfectants against human NoV. Monoclonal antibodies against Norwalk virus (NV, GI.1) and NoV GII.4 were produced using unique NoV capsid proteins, and the antibodies were conjugated to magnetic Dynalbeads. The immunomagnetic beads were used to simultaneously capture intact NoV in samples and effectively remove PCR inhibitors. We examined the efficacy of ethanol, sodium hypochlorite, nine commercially available disinfectants, and one prototype disinfectant using the IMS/RT-qPCR. The sensitivity of this procedure was approximately 100 virus particles for both the NV and GII.4 viruses. The average log reductions in in vitro activities varied between disinfectants. The prototype disinfectant produced an average 3.19-log reduction in NV and a 1.38-log reduction in GII.4. The prototype disinfectant is promising of inactivating NoV. This method can be used to evaluate in vitro activity of disinfectants against human NoV. The IMS/RT-qPCR method is promising as an effective method to remove PCR inhibitors in disinfectants and enable the evaluation of the efficacy of disinfectants.",
keywords = "Disinfectant, Immunomagnetic separation, Norovirus, PCR inhibition, Real-time RT-PCR",
author = "Pengbo Liu and Myung Kim and David Schlesinger and Christine Kranz and Sangdo Ha and Jeehyoung Ha and James Slauch and Seungbum Baek and Christine Moe",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.jiph.2014.08.007",
language = "English (US)",
volume = "8",
pages = "145--154",
journal = "Journal of Infection and Public Health",
issn = "1876-0341",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Immunomagnetic separation combined with RT-qPCR for determining the efficacy of disinfectants against human noroviruses

AU - Liu, Pengbo

AU - Kim, Myung

AU - Schlesinger, David

AU - Kranz, Christine

AU - Ha, Sangdo

AU - Ha, Jeehyoung

AU - Slauch, James

AU - Baek, Seungbum

AU - Moe, Christine

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Little is known about the effectiveness of disinfectants against human noroviruses (NoV) partially because human NoV cannot be routinely cultured in laboratory. The objective of this study was to develop a NoV monoclonal antibody-conjugated immunomagnetic separation (IMS) procedure combined with real-time reverse transcription polymerase chain reaction (RT-qPCR) assays to study the in vitro efficacy of disinfectants against human NoV. Monoclonal antibodies against Norwalk virus (NV, GI.1) and NoV GII.4 were produced using unique NoV capsid proteins, and the antibodies were conjugated to magnetic Dynalbeads. The immunomagnetic beads were used to simultaneously capture intact NoV in samples and effectively remove PCR inhibitors. We examined the efficacy of ethanol, sodium hypochlorite, nine commercially available disinfectants, and one prototype disinfectant using the IMS/RT-qPCR. The sensitivity of this procedure was approximately 100 virus particles for both the NV and GII.4 viruses. The average log reductions in in vitro activities varied between disinfectants. The prototype disinfectant produced an average 3.19-log reduction in NV and a 1.38-log reduction in GII.4. The prototype disinfectant is promising of inactivating NoV. This method can be used to evaluate in vitro activity of disinfectants against human NoV. The IMS/RT-qPCR method is promising as an effective method to remove PCR inhibitors in disinfectants and enable the evaluation of the efficacy of disinfectants.

AB - Little is known about the effectiveness of disinfectants against human noroviruses (NoV) partially because human NoV cannot be routinely cultured in laboratory. The objective of this study was to develop a NoV monoclonal antibody-conjugated immunomagnetic separation (IMS) procedure combined with real-time reverse transcription polymerase chain reaction (RT-qPCR) assays to study the in vitro efficacy of disinfectants against human NoV. Monoclonal antibodies against Norwalk virus (NV, GI.1) and NoV GII.4 were produced using unique NoV capsid proteins, and the antibodies were conjugated to magnetic Dynalbeads. The immunomagnetic beads were used to simultaneously capture intact NoV in samples and effectively remove PCR inhibitors. We examined the efficacy of ethanol, sodium hypochlorite, nine commercially available disinfectants, and one prototype disinfectant using the IMS/RT-qPCR. The sensitivity of this procedure was approximately 100 virus particles for both the NV and GII.4 viruses. The average log reductions in in vitro activities varied between disinfectants. The prototype disinfectant produced an average 3.19-log reduction in NV and a 1.38-log reduction in GII.4. The prototype disinfectant is promising of inactivating NoV. This method can be used to evaluate in vitro activity of disinfectants against human NoV. The IMS/RT-qPCR method is promising as an effective method to remove PCR inhibitors in disinfectants and enable the evaluation of the efficacy of disinfectants.

KW - Disinfectant

KW - Immunomagnetic separation

KW - Norovirus

KW - PCR inhibition

KW - Real-time RT-PCR

UR - http://www.scopus.com/inward/record.url?scp=84933676534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933676534&partnerID=8YFLogxK

U2 - 10.1016/j.jiph.2014.08.007

DO - 10.1016/j.jiph.2014.08.007

M3 - Article

C2 - 25270388

AN - SCOPUS:84933676534

VL - 8

SP - 145

EP - 154

JO - Journal of Infection and Public Health

JF - Journal of Infection and Public Health

SN - 1876-0341

IS - 2

ER -